Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of maraviroc intensification in HIV-1 patients with poor immune reconstitution despite virologic suppression
2009-011171-76Phase 2Completed
- Sponsor
- ANRS
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aprepitant in Human immunodeficiency virus infection type 1, sponsored by ANRS. Primary endpoint: Absolute and percentage CD4 gain from baseline to week 24. Started Apr 2009; status: completed.
02
Drugs
aprepitant
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2009-011171-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011171-76.